D. D'Agostino

A Meta-Analysis on the Interaction between HER-2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer

G. Tortora, F. Ciardiello, G. Arpino, 2005, Clinical Cancer Research.

Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab

E. Montagna, G. Cancello, A. Esposito, 2008, Cancer Chemotherapy and Pharmacology.

Gemcitabine, ifosfamide and paclitaxel in advanced/metastatic non-small cell lung cancer patients: a phase II study

G. Mazzarella, S. Marsico, F. Piantedosi, 2008, Cancer Chemotherapy and Pharmacology.

A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach.

R. Piccoli, R. Piccoli, P. Sabatini, 2009, Autoimmunity reviews.

Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials.

C. Criscitiello, A. Giordano, A. Bianco, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

AMeta-Analysis on the Interaction between HER-2 Expression and Response to EndocrineTreatment in Advanced Breast Cancer

F. Ciardiello, G. Arpino, A. Bianco, 2005 .

Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.

R. Torella, M. Persico, M. Romano, 2008, Journal of hepatology.

Estimation of bulky lymph nodes by power Doppler ultrasound scanning in patients with Hodgkin's lymphoma: a prospective study.

M. Salvatore, E. Nicolai, F. Pane, 2006, Haematologica.

Continuing trastuzumab beyond disease progression: outcomes analysis in patients with metastatic breast cancer

A. Giordano, G. Di Lorenzo, M. De Laurentiis, 2008, Breast Cancer Research.

Analytical and clinical performance characteristics of Hybritech's Tandem-R free PSA assay during a large multicenter clinical trial to determine the clinical utility of percentage of free prostate-specific antigen.

D. Chan, J. Beck, D. Lamb, 1999, Clinical chemistry.